Full Text
Persistence of Remission Among Patients With Inflammatory Bowel Disease After Adalimumab Therapy Is Stopped- Economic Implications

Abstract

Authors

J Borras Blasco X Cortes S Fernandez J Moles M Castera

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×